Dynavax Technologies | DVAX - Market Capitalization


Dynavax Technologies reported $2.04B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Adma Biologics USD 4.34B 845M Dec/2025
Agenus USD 107M 16M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025